{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:58:45Z","timestamp":1791291525756,"version":"4.3.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1136\/ard.62.4.297","type":"journal-article","created":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T00:01:21Z","timestamp":1047513681000},"page":"297-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"62","author":[{"given":"M","family":"Cutolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ghiorzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pizzorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Craviotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Villaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.4.297_bib1","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","article-title":"Human leukocyte subpopulation from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules","volume":"166","author":"Salmi","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.4.297_bib2","first-page":"1464","article-title":"Understanding rheumatoid arthritis","volume":"24","author":"Ford","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.4.297_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1749-6632.1999.tb07620.x","article-title":"Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic disease","volume":"876","author":"Cutolo","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1136\/ard.62.4.297_bib4","first-page":"253","article-title":"Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans","volume":"49","author":"Fairbanks","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.62.4.297_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.bi.49.070180.001345","article-title":"Pyrimidine nucleotide biosynthesis in animals genes, enzymes, and regulation of UMP biosynthesis","volume":"49","author":"Jones","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"10.1136\/ard.62.4.297_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01796261","article-title":"Leflunomide interferes with pyrimidine nucleotide biosynthesis","volume":"44","author":"Cherwinsky","year":"1995","journal-title":"Inflamm Res"},{"key":"10.1136\/ard.62.4.297_bib7","first-page":"1016","article-title":"Mechanism of the anti-proliferative action of leflunomide","volume":"14","author":"Cao","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1136\/ard.62.4.297_bib8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0041-1345(96)00523-4","article-title":"In vitro and in vivo effects of leflunomide, brequiner, cyclosporin on pyrimidine biosynthesis","volume":"29","author":"Silva","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1136\/ard.62.4.297_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/bi952168g","article-title":"The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihyrdoorotate dehydrogenase","volume":"35","author":"Davis","year":"1996","journal-title":"Biochemistry"},{"key":"10.1136\/ard.62.4.297_bib10","doi-asserted-by":"crossref","first-page":"29682","DOI":"10.1074\/jbc.270.50.29682","article-title":"Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibition","volume":"270","author":"Fairbanks","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.62.4.297_bib11","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1074\/jbc.270.21.12398","article-title":"Inhibition of protein tyrosin phosphorylation in T cells by a novel immunosuppressive agent, leflunomide","volume":"270","author":"Xu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.62.4.297_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01987669","article-title":"Inhibition of interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide","volume":"41","author":"Nikcevich","year":"1994","journal-title":"Agent Actions"},{"key":"10.1136\/ard.62.4.297_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780380202","article-title":"Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-\u03b1 in rheumatoid arthritis","volume":"38","author":"Arend","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.4.297_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.159.1.22","article-title":"The immunosuppressive metabolite of leflunomide A771726, affects murine T cells through two biochemical mechanism","volume":"159","author":"Elder","year":"1997","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.4.297_bib15","series-title":"T cells arthritis","first-page":"111","article-title":"Interactions between T cell plasma membrane and monocytes","author":"Burger","year":"1998"},{"key":"10.1136\/ard.62.4.297_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0952-7915(96)80090-2","article-title":"Molecular mechanism of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK 506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide","volume":"8","author":"Brazleton","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1136\/ard.62.4.297_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00007890-199601150-00026","article-title":"Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro","volume":"61","author":"Chong","year":"1996","journal-title":"Transplantation"},{"key":"10.1136\/ard.62.4.297_bib18","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/1529-0131(200008)43:8<1820::AID-ANR18>3.0.CO;2-D","article-title":"Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis","volume":"4","author":"Kraan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.4.297_bib19","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.4049\/jimmunol.165.10.5962","article-title":"Leflunomide suppresses TNF-induced cellular responses: effects of NF-kB, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis","volume":"165","author":"Manna","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.4.297_bib20","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.162.4.2095","article-title":"Immunosuppressive leflunomide metabolite (A 77 1726) blocks TNF-dependent nuclear factor-kB activation and gene expression","volume":"162","author":"Manna","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.4.297_bib21","first-page":"723","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.4.297_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0162-3109(00)00191-0","article-title":"Hermann ML, Schleyerback R, Krischbaum BJ. Leflunomide, an immunomodulatory drug for the treatment of rheumatoid artritis and other autoimmune disease","volume":"47","author":"Scott","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1136\/ard.62.4.297_bib23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/eji.1830200727","article-title":"Simultaneous production of interleukin-2, interleukin-4 and interferon-\u03b3 by activated human blood lymphocytes","volume":"20","author":"Andersson","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.62.4.297_bib24","first-page":"663","article-title":"Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitors of metalloproteinase-1 over that of interleukin-1\u03b2 and metalloproteinases","volume":"9","author":"Deage","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.62.4.297_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.62.4.297_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(96)00303-6","article-title":"Two activities of the immunosuppressive metabolite of leflunomide, A771726: inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation","volume":"52","author":"Xu","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1136\/ard.62.4.297_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0702708","article-title":"A771726, the active metabolite of leflunomide, directly inhibits activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner","volume":"127","author":"Halminton","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1136\/ard.62.4.297_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02001911","article-title":"Effects of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation","volume":"4","author":"Weithmann","year":"1994","journal-title":"Agents Actions"},{"key":"10.1136\/ard.62.4.297_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/38.8.779","article-title":"Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2","volume":"38","author":"Brooks","year":"1999","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.62.4.297_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/art.10084","article-title":"Comparative assessment of leflunomide and methotrexate for the treatments of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging","volume":"46","author":"Recee","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.4.297_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Antiinflammatory mechanisms of methotrexate in rheumatoid arthritis","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.62.4.297_bib32","first-page":"2551","article-title":"Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from rheumatoid arthritis patients","volume":"27","author":"Cutolo","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.4.297_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/40.4.367","article-title":"Treatment-induced remisssion in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies","volume":"40","author":"Smith","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.62.4.297_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1749-6632.2002.tb04220.x","article-title":"Antiproliferative and antiinflammatory effects of methotrexate and sex hormones on cultured differentiating myeloid monocytic cells (THP-1)","volume":"966","author":"Cutolo","year":"2002","journal-title":"Ann N Y Acad Sci"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724090344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724090344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.4.297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:45:24Z","timestamp":1736066724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724090344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S0003496724090344"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.4.297","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.4.297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}